Pain News and Research

Latest Pain News and Research

New challenges to military medicine

Better body armor and rapid aeromedical evacuations enable American service members to survive blasts that would have proved fatal in Vietnam or even the first Gulf War, but they pose new challenges to military medicine - how to deal with the excruciating pain of injuries, especially severe burns from IED blasts that body armor can't protect.

13 May 2013

Viewpoints: The threat from 'contagion exhaustion;' An economist sees humor in hospital pricing

There has been a flurry of recent attention over two novel infectious agents: the first, a strain of avian influenza virus (H7N9) in China that is causing severe respiratory disease and other serious health complications in people; the second, a coronavirus, first reported last year in the Middle East, that has brought a crop of new infections.

13 May 2013

Research: Patients with chronic pain should be evaluated for anxiety disorders

Patients coping with chronic pain should also be evaluated for anxiety disorders, according to new research published in General Hospital Psychiatry.

13 May 2013

UI professor highlights future challenges for improving tools for evaluating pain in older people

Although several types of pain assessment tools are available to help clinicians evaluate pain in older people, too often the sole initial emphasis is to gauge pain intensity instead of determining how the pain affects function and the need for treatment, according to research presented at the American Pain Society Annual Scientific Meeting.

13 May 2013

New 3-D technology to see precise source of atrial fibrillation in the heart

Researchers at the Intermountain Heart Institute at Intermountain Medical Center have developed a new 3-D technology that for the first time allows cardiologists the ability to see the precise source of atrial fibrillation in the heart - a breakthrough for a condition that affects nearly three million Americans.

13 May 2013

Study: Toddlers living in socially-deprived areas are at greatest risk of scald

Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.

10 May 2013

Nutritional supplement may improve survival rates of babies born with heart defects

A common nutritional supplement may be part of the magic in improving the survival rates of babies born with heart defects, researchers report. Carnitine, a compound that helps transport fat inside the cell powerhouse where it can be used for energy production, is currently used for purposes ranging from weight loss to chest pain.

10 May 2013

DURECT: Pfizer provides update on investigational drug Remoxy

DURECT Corporation today announced that Pfizer has provided an update on Remoxy as part of their Form 10-Q filing.

10 May 2013

NINDS Director affirms NIH's committed to support pain research at APS meeting

In her keynote address to the 32nd American Pain Society Annual Scientific Conference, Story Landis, PhD, director of the National Institute for Neurological Disorders and Stroke, told the APS audience that NIH is committed to research to improve understanding of the biological basis of pain and the development of effective treatments.

10 May 2013

Headline results of Creabilis' CT327 Phase 2b trial in psoriasis patients announced

Creabilis, a late stage European dermatology company with a focus on chronic pruritus (itch), today announces headline results of its Phase 2b trial with its lead product, CT327, in psoriasis patients.

10 May 2013

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Novartis announced that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older.

10 May 2013

InSite Vision starts patient enrollment in confirmatory Phase 3 clinical trial of BromSite

InSite Vision Incorporated today announced that patient enrollment has begun in the confirmatory Phase 3 clinical trial of BromSite (ISV-303) for the reduction of inflammation and pain after cataract surgery.

10 May 2013

Nearly 1/10 stroke patients suffer from chronic and debilitating pain

Nearly 1 in 10 stroke patients suffer chronic and debilitating pain, typically described as sharp, stabbing or burning. It's called central poststroke pain syndrome (CPSP). It was first described more than 100 years ago, and it is treatable with medications and magnetic or electrical stimulation of the brain.

9 May 2013

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.

9 May 2013

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials.

9 May 2013

UA researchers discover genetic mutations that cause severe epilepsies in children

Researchers at the University of Arizona have successfully determined the genetic mutations causing severe epilepsies in seven out of 10 children for whom the cause of the disorder could not be determined clinically or by conventional genetic testing.

9 May 2013

Using copper IUD or coil does not exacerbate period pain, reveals study

Using a copper intrauterine device (IUD), or coil, does not exacerbate period pain, reveals a study where researchers from the Sahlgrenska Academy, University of Gothenburg, Sweden, followed 2,100 women for 30 years.

8 May 2013

POZEN announces revenue of $1.4 million for first quarter 2013

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2013.

8 May 2013

Heart Rhythm Society launches Citywide Awareness Campaign in Denver about cardiac arrhythmia

Colorado Governor John W. Hickenlooper has proclaimed May to be Cardiac Arrhythmia Awareness Month (#RhythmAwareness), calling attention to the need for greater public awareness throughout the State about two serious heart rhythm disorders, atrial fibrillation (also known as AF or AFib) and sudden cardiac arrest (also known as SCA).

8 May 2013

Study reports that less-invasive option for spinal stenosis poses 'trade-off' in outcomes

Interspinous spacer implantation-a less-invasive alternative surgical option for spinal stenosis-has a lower complication rate than spinal fusion, reports a study in the May 1 issue of Spine The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

8 May 2013

Pain News and Research

Latest Pain News and Research

New challenges to military medicine

Viewpoints: The threat from 'contagion exhaustion;' An economist sees humor in hospital pricing

Research: Patients with chronic pain should be evaluated for anxiety disorders

UI professor highlights future challenges for improving tools for evaluating pain in older people

New 3-D technology to see precise source of atrial fibrillation in the heart

Study: Toddlers living in socially-deprived areas are at greatest risk of scald

Nutritional supplement may improve survival rates of babies born with heart defects

DURECT: Pfizer provides update on investigational drug Remoxy

NINDS Director affirms NIH's committed to support pain research at APS meeting

Headline results of Creabilis' CT327 Phase 2b trial in psoriasis patients announced

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

InSite Vision starts patient enrollment in confirmatory Phase 3 clinical trial of BromSite

Nearly 1/10 stroke patients suffer from chronic and debilitating pain

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

UA researchers discover genetic mutations that cause severe epilepsies in children

Using copper IUD or coil does not exacerbate period pain, reveals study

POZEN announces revenue of $1.4 million for first quarter 2013

Heart Rhythm Society launches Citywide Awareness Campaign in Denver about cardiac arrhythmia

Study reports that less-invasive option for spinal stenosis poses 'trade-off' in outcomes

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Newsletters you may be interested in